1-1 of 1
Philip Hall, Pharm.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Use of DT388-IL3 Fusion Protein in Patients with Refractory Acute Myeloid Leukemia(AML).

Debashish Misra, M.D., Arthur Frankel, M.D., Philip Hall, Pharm.D., Tie Fu Liu, M.D., Jennifer Black, R.N., Joseph O. Moore, M.D., Carlos de Castro, M.D., Jon P. Gockerman, M.D., Cristina Gasparetto, M.D., Mitchell Horwitz, M.D., Patricia H. Davis, R.N., Nelson J. Chao, M.D., David A. Rizzieri, M.D.
Journal: Blood
Blood (2004) 104 (11): 4513.
https://doi.org/10.1182/blood.V104.11.4513.4513
Published: 2004